<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00800969</url>
  </required_header>
  <id_info>
    <org_study_id>VIS-UGI-1</org_study_id>
    <nct_id>NCT00800969</nct_id>
  </id_info>
  <brief_title>Prospective Evaluation of the Preoperative Lymph Node Staging in Patients With Cancer of the Esophagogastric Junction and Stomach</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <brief_summary>
    <textblock>
      This prospective study includes patients with histologically proven cancer of the
      esophagogastric junction (Siewert Type II and III) and the stomach. Aim of the study is to
      evaluate the accuracy of PET-CT for the preoperative assessment of lymph node metastasis. The
      evaluation includes a combination with standard diagnostic tools (endoluminal ultrasound, CT
      and diagnostic laparoscopy prior to neoadjuvant therapy). Standardized D2-lymphadenectomy is
      performed and individual lymph node stations (Nr 1-12 according to the Japanese
      classification) are histopathologically examined. Furthermore we evaluate the role of the
      PET-CT for early metabolic response evaluation in patients receiving neoadjuvant
      chemotherapy.

        -  Trial with surgical intervention
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date>October 2008</start_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic Accuracy of PET-CT</measure>
    <time_frame>preoperative</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Adenocarcinoma</condition>
  <condition>Stomach Cancer</condition>
  <condition>Cancer of Esophagogastric Junction</condition>
  <arm_group>
    <arm_group_label>all patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>all patients with Adenocarcinoma</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>FDG-PET-CT</intervention_name>
    <description>Radiologic standard procedure</description>
    <arm_group_label>all patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Histological prove of adenocarcinoma of the stomach.

        Exclusion criteria:

          -  Recurrent gastric carcinoma

          -  No informed consent

          -  Previous malignancy (exception: thyroid, bladder in situ, Cervix in situ)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kuno Lehmann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Visceral surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2008</study_first_submitted>
  <study_first_submitted_qc>December 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2008</study_first_posted>
  <last_update_submitted>June 22, 2016</last_update_submitted>
  <last_update_submitted_qc>June 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Adenocarcinoma of the stomach and esophagogastric junction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

